Pelthos Therapeutics Inc.
PTHS· NYSE
Released Nov 13, 2024, after the close
10-Q filed Nov 13, 2024, 44 days after period end · 0001753926-24-001883
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2024 | Q3 2023 |
|---|---|---|
| Net Income | -$1.70M | -$1.42M |
| EPS Diluted | -$2.93 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pelthos Therapeutics Inc. · CIK 1919246 · Engraved from SEC EDGAR
ended Sep 30, 2024 · filed Nov 13, 2024 · 44 d after period end